Promising Adjunct Medicines in the Protocol of COVID-19 Clinical Trial
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative organism ofCOVID-19. Since this disease is considered new and does not have an approved curativeprotocol, many researchers have tackled the possible options for COVID-19 prevention andtherapeutic approaches. We address her...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Tabriz University of Medical Sciences,
2022-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |